Trial Profile
A phase III, multi-center, randomized, double-blind, placebo-controlled, parallel group trial of 14 day treatment with lansoprazole 15 mg once a day in frequent heartburn
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Sep 2009
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Heartburn
- Focus Therapeutic Use
- Sponsors Novartis
- 01 Jul 2009 Primary endpoint 'Symptom free days' has been met.
- 01 Jul 2009 Results have been reported in Postgraduate Medicine.
- 12 Jan 2007 Status change